Biotech
27 total deals across 22 companies.
Latest Funding
Company
Location
Latest Round
Amount
Date
Efferon
Villach, Austria
—
Seed
$2.9M
May 21, 2026
Imperagen
Manchester, United Kingdom
—
Seed
$6.8M
May 21, 2026
QuberTech
Harpenden, United Kingdom
—
Funding
$4.6M
May 20, 2026
Cellogen Therapeutics
Noida, India
—
Funding
$2.0M
May 19, 2026
Alcolase
Copenhagen, Denmark
—
Seed
$1.7M
May 18, 2026
Melazyme
Singapore
—
Seed
$2.0M
May 14, 2026
Resurrect Bio
United Kingdom
—
Series A
$8.8M
May 14, 2026
Isomorphic Labs
London, United Kingdom
—
Series B
$2.1B
May 12, 2026
Tolemy Bio
Cambridge, United Kingdom
—
Pre-Seed
$1.5M
May 12, 2026
Algorithmiq
Milan, Italy
—
Series B
$21.0M
May 11, 2026
Cellply
Bologna, Italy
—
Growth
$8.3M
May 11, 2026
NanoStruct
Würzburg, Germany
—
Seed
$3.0M
May 11, 2026
Meatly
London, United Kingdom
—
Series A
$12.9M
May 7, 2026
Cytospire Therapeutics
London, United Kingdom
—
Series A
$61.0M
May 6, 2026
EnteroBiotix
Bellshill, United Kingdom
—
Growth
$25.0M
May 4, 2026
Moleculent
Solna, Sweden
—
Growth
$20.0M
May 4, 2026
BioOrbit
United Kingdom
—
Seed
$13.2M
Apr 30, 2026
STORM Therapeutics
Cambridge, United Kingdom
—
Series C
$51.5M
Apr 16, 2026
Generare
Paris, France
—
Series A
$21.6M
Apr 2, 2026
Semarion
Cambridge, United Kingdom
—
Seed
$3.8M
Mar 31, 2026
Parabilis Medicines
Cambridge, United States
—
Series F
$305.0M
Jan 8, 2026
CrisprBits
Bangalore, India
—
Pre-Series A
$3.0M
Nov 1, 2025